Figure 3From: Insulinlike Growth Factor (IGF)-1 Administration Ameliorates Disease Manifestations in a Mouse Model of Spinal and Bulbar Muscular AtrophyIGF-1 ameliorates SBMA muscle pathology. (A) Hematoxylin and eosin staining. Arrows = fibers with central nuclei; asterisks = angulated and grouped fibers. (B) Nicotinamide adenine dinucleotide staining. Asterisks = moth-eaten fibers. (C) Histograms of myofiber cross-sectional area (CSA). (D) Muscle cross-sectional area (CSA) and (E) minimal Feret diameter were increased in SBMA mice treated with IGF-1 compared with vehicle (*p × 0.05; **p < 0.01.). Transverse sections of quadriceps of 16-wk-old SBMA mice and wild-type litter-mates are shown.Back to article page